Compounds are provided of the following structure are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol, and treating hyperlipidemia and dyslipidemia, hypercholesterolemia, hypertriglyceridemia and atherosclerosis ##STR00001## wherein variables A and B are defined herein.

 
Web www.patentalert.com

< Melanin concentrating hormone receptor antagonist

> Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

> Benzamide derivatives and uses related thereto

~ 00577